XR
XRF Scientific Limited
XRF.AX · ASX
$1.79 +0.56% (+$0.01)
1M -2.19%
Market Cap $256.0M
P/E Ratio 24.41x
Div. Yield 2.51%
ROE 17.33%
Bulios Fair Price
$1.12
37.4% downside
Current Price
$1.79
Undervalued Fair Value Overvalued
According to Bulios Fair Price, XRF.AX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
44 /100
Fair P/E 24.41x
PEG 24.21x
EV/EBITDA 13.29x
Growth
56 /100
Stable EPS growth 8.91%
Book val. growth 10.47%
Rev. growth 5.14%
Profitability
94 /100
Strong Gross margin 46.94%
FCF margin 15.10%
Net margin 16.35%
Quality
84 /100
Excellent ROIC 16.31%
Asset turnover 0.82x
ROE 17.33%
Debt
100 /100
Low Debt/Equity 0.04x
Net debt/EBITDA -0.38x
Current ratio 4.96x
Stability
100 /100
Stable Beta 0.62x
Profitable years 6
Rev. volatility 5.09%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about XRF.AX
Online
Sector
Industrials
Industry
Industrial - Machinery
CEO
Vance Stazzonelli
Employees
48
Headquarters
Osborne Park
Upcoming events
22 FEB
Earnings
Upcoming earnings report